Skip to main content
Top
Published in: Indian Journal of Hematology and Blood Transfusion 1/2014

01-09-2014 | Case Report

Primary Bone Marrow Lymphoma Presenting with Cold-Type Autoimmune Hemolytic Anemia

Authors: Shigeki Kosugi, Mai Watanabe, Masahiro Hoshikawa

Published in: Indian Journal of Hematology and Blood Transfusion | Special Issue 1/2014

Login to get access

Abstract

We report a rare case of primary bone marrow lymphoma with cold-type autoimmune hemolytic anemia (AIHA). A 70-year-old Japanese woman with suspected liver disorder presented to our hospital with palpitation. On physical examination, she had jaundice and signs of anemia. No lymphadenopathy or hepatosplenomegaly was noted. A direct antiglobulin test was positive for complement C3b and C3d. Anti-IgG testing was negative. Cold agglutinin was positive with a titer of 1:≥8,192, and haptoglobin was absent. A diagnosis of cold-type AIHA was made. Bone marrow biopsy revealed involvement with a population of lymphocytes that were positive for CD20 (L-26), CD79a, and Bcl-2. No lymphoma lesion was detected on computerized tomography or on upper and lower endoscopy. The patient was diagnosed with diffuse large B cell lymphoma (DLBCL) presenting with cold-type AIHA. She was treated with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone, resulting in complete remission after six cycles. As of 22 months after presentation, no signs of cold-type AIHA or lymphoma were present.
Literature
1.
go back to reference Genry I, Michel M, Hermine O et al (2002) Characteristics of autoimmune hemolytic anemia in adults: retrospective analysis of 83 cases. Rev Med Intern 23:901–909CrossRef Genry I, Michel M, Hermine O et al (2002) Characteristics of autoimmune hemolytic anemia in adults: retrospective analysis of 83 cases. Rev Med Intern 23:901–909CrossRef
2.
go back to reference Berentsen S, Ulvestad E, Langholm R et al (2006) Primary chronic cold agglutinin disease: a population based clinical study of 86 patients. Haematologica 91:460–466PubMed Berentsen S, Ulvestad E, Langholm R et al (2006) Primary chronic cold agglutinin disease: a population based clinical study of 86 patients. Haematologica 91:460–466PubMed
3.
go back to reference Berentsen S, Beiske K, Tjonnfjold GE (2007) Primary chronic cold agglutinin disease: an update on pathogenesis, clinical features and therapy. Hematology 12:361–370PubMedCrossRefPubMedCentral Berentsen S, Beiske K, Tjonnfjold GE (2007) Primary chronic cold agglutinin disease: an update on pathogenesis, clinical features and therapy. Hematology 12:361–370PubMedCrossRefPubMedCentral
4.
go back to reference Berentsen S (2011) How manage cold agglutinin disease. British J Hematol 153:309–317CrossRef Berentsen S (2011) How manage cold agglutinin disease. British J Hematol 153:309–317CrossRef
5.
go back to reference Sumi M, Ichikawa N, Shimizu I et al (2007) Primary diffuse large B-cell lymphoma of the bone marrow complicated with autoimmune hemolytic anemia and erythroid hypoplasia. Rinsho Ketsueki 48(7):571–575PubMed Sumi M, Ichikawa N, Shimizu I et al (2007) Primary diffuse large B-cell lymphoma of the bone marrow complicated with autoimmune hemolytic anemia and erythroid hypoplasia. Rinsho Ketsueki 48(7):571–575PubMed
6.
go back to reference Ni Áinle F, Hamnvik OP, Glumann C et al (2008) Diffuse large B-cell lymphoma with isolated bone marrow involvement presenting with secondary cold agglutinin disease. Int J Lab Hematol 30(5):444–445CrossRef Ni Áinle F, Hamnvik OP, Glumann C et al (2008) Diffuse large B-cell lymphoma with isolated bone marrow involvement presenting with secondary cold agglutinin disease. Int J Lab Hematol 30(5):444–445CrossRef
7.
go back to reference Czuczman MS, Grillo-López AJ, White CA et al (1999) Treatment of patients with low-grade B-cell lymphoma with the combination of chimeric ant-CD20 monoclonal antibody and CHOP chemotherapy. J Clin Oncol 17(1):268–276PubMed Czuczman MS, Grillo-López AJ, White CA et al (1999) Treatment of patients with low-grade B-cell lymphoma with the combination of chimeric ant-CD20 monoclonal antibody and CHOP chemotherapy. J Clin Oncol 17(1):268–276PubMed
8.
go back to reference Martinez A, Ponzoni M, Agostinelli C et al (2012) Primary bone marrow lymphoma: an uncommon extranodal presentation of aggressive non-Hodgkin lymphomas. Am J Surg Pathol 36(2):296–304PubMedCrossRef Martinez A, Ponzoni M, Agostinelli C et al (2012) Primary bone marrow lymphoma: an uncommon extranodal presentation of aggressive non-Hodgkin lymphomas. Am J Surg Pathol 36(2):296–304PubMedCrossRef
9.
go back to reference Alvares CL, Matutes E, Scully MA et al (2004) Isolated bone marrow involvement in diffuse large B cell lymphoma: a report of three cases with review of morphological, immunophenotypic and cytogenetic findings. Leuk Lymphoma 45(4):769–775PubMedCrossRef Alvares CL, Matutes E, Scully MA et al (2004) Isolated bone marrow involvement in diffuse large B cell lymphoma: a report of three cases with review of morphological, immunophenotypic and cytogenetic findings. Leuk Lymphoma 45(4):769–775PubMedCrossRef
10.
go back to reference Jaffe ES, Harris NL, Stein H et al (2008) Introduction and overview of the classification of the lymphoid neoplasms. WHO classification of tumors of haematopoietic and lymphoid tissues. International Agency for Research on Cancer Press, Lyon Jaffe ES, Harris NL, Stein H et al (2008) Introduction and overview of the classification of the lymphoid neoplasms. WHO classification of tumors of haematopoietic and lymphoid tissues. International Agency for Research on Cancer Press, Lyon
Metadata
Title
Primary Bone Marrow Lymphoma Presenting with Cold-Type Autoimmune Hemolytic Anemia
Authors
Shigeki Kosugi
Mai Watanabe
Masahiro Hoshikawa
Publication date
01-09-2014
Publisher
Springer India
Published in
Indian Journal of Hematology and Blood Transfusion / Issue Special Issue 1/2014
Print ISSN: 0971-4502
Electronic ISSN: 0974-0449
DOI
https://doi.org/10.1007/s12288-014-0356-6

Other articles of this Special Issue 1/2014

Indian Journal of Hematology and Blood Transfusion 1/2014 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine